分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Glioblastoma-secreted C1QL1 orchestrates tumor microtube expansion and neural synaptic pruning to drive malignant synapse formation and recurrence

Ding Chaoqiong, Dong Jiayi, Pan Zhenzhong, Liu Shijie, Song Qiuyue, Yang Gaoxia, Peng Yuling, Xie Chuanxing, Huang Zongyao, Yao Wei, Wu Mengnan, Zhong Yi, Zhang Wei, Zhang Yan, Wang Songhua, Ma Weiwe

Journal:Cancer Discovery

IF:29.5

DOI:10.1158/2159-8290.CD-25-1123

PMID:41747254

Published:2026-02-27

research field:肿瘤学肿瘤微环境癌症生物学神经生物学分子信号传导

Abstract

Glioblastoma (GBM) cells form neuron-to-glioma malignant synapses on neurite-like tumor microtubes (TMs), driving infiltrative growth and recurrence. The mechanisms underlying coordinated crosstalk among GBM cells and with neurons to favor malignant over normal synapses remain largely unknown. Here, we demonstrate that glioma-secreted C1QL1 is a key messenger for glioma-neuron and glioma-glioma crosstalk to drive TM expansion and malignant synapse formation. C1QL1 binds to its receptor BAI3 on neighboring neurons and GBM cells, activating Rac1-mediated cytoskeleton rearrangement to prune normal synapses and outgrow TMs, promoting malignant synapse and glioma network formation. Targeted treatment with a non-GEF-targeting, first-in-class Rac1 inhibitor rescues C1QL1-mediated synaptic pruning, inhibiting TMs and malignant synapses to impede glioma recurrence. Our findings elucidate how crosstalk among GBM cells and neurons allows infiltrating GBM cells to sculpt and integrate into the existing neural network, highlighting a therapeutic strategy against GBM recurrence through simultaneous inhibition of TMs and glioma-induced synaptic pruning.

本文使用的Yeasen产品

购物车
客服
转染试用